5-methylurapidil has been researched along with phenoxybenzamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, K; Suzuki, E; Tamura, K; Tsujimoto, G | 1 |
| Docherty, JR; Kearns, S; O'Rourke, M | 1 |
| Arai, M; Fujiwara, H; Fujiwara, T; Kariya, T; Koshiji, M; Minatoguchi, S; Ohno, T; Uno, Y; Yamashita, K | 1 |
| Amobi, N; Coker, C; Guillebaud, J; Mulvin, D; Smith, IC | 1 |
| Koss, MC; Yu, Y | 2 |
6 other study(ies) available for 5-methylurapidil and phenoxybenzamine
| Article | Year |
|---|---|
Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role.
Topics: Adrenergic alpha-Antagonists; Animals; Aorta; Binding Sites; Calcium; Clonidine; Dioxanes; In Vitro Techniques; Models, Biological; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenethylamines; Phenoxybenzamine; Piperazines; Rabbits; Receptors, Adrenergic, alpha; Signal Transduction; Tetralones; Vasoconstriction | 1990 |
Investigation of the actions of chloroethylclonidine in rat aorta.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Aorta; Clonidine; Cystamine; Dioxanes; Dose-Response Relationship, Drug; Drug Synergism; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Oxathiins; Phenoxybenzamine; Phentolamine; Piperazines; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Spiperone; Xylazine; Yohimbine | 1995 |
Infarct size-reducing effect of ischemic preconditioning is related to alpha1b-adrenoceptors but not to alpha1a-adrenoceptors in rabbits.
Topics: Adrenergic alpha-Antagonists; Animals; Clonidine; Ischemic Preconditioning, Myocardial; Male; Phenoxybenzamine; Piperazines; Quinazolines; Rabbits; Receptors, Adrenergic, alpha-1 | 1997 |
Functional characterization of alpha1-adrenoceptor subtypes in longitudinal and circular muscle of human vas deferens.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Alkylating Agents; Binding, Competitive; Clonidine; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Norepinephrine; Phenoxybenzamine; Piperazines; Prazosin; Receptors, Adrenergic; Spiperone; Vas Deferens | 1999 |
Functional characterization of alpha-adrenoceptors mediating pupillary dilation in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic Fibers; Animals; Dioxanes; Dose-Response Relationship, Drug; Electric Stimulation; Injections, Intravenous; Male; Mydriasis; Norepinephrine; Phenoxybenzamine; Phentolamine; Piperazines; Prazosin; Pupil; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Yohimbine | 2003 |
Studies of alpha-adrenoceptor antagonists on sympathetic mydriasis in rabbits.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Electric Stimulation; Isoquinolines; Male; Mydriasis; Mydriatics; Naphthyridines; Phenoxybenzamine; Phentolamine; Piperazines; Prazosin; Pupil; Rabbits; Sympathetic Nervous System | 2003 |